Systems and methods for revascularization assessment
US-2020093382-A1 · Mar 26, 2020 · US
US11206990B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11206990-B2 |
| Application number | US-201414155015-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 14, 2014 |
| Priority date | Jan 23, 2013 |
| Publication date | Dec 28, 2021 |
| Grant date | Dec 28, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Blood flow rates can be calculated using diffuse speckle contrast analysis in spatial and time domains. In the spatial domain analysis, a multi-pixel image sensor can be used to detect a spatial distribution of speckles in a sample caused by diffusion of light from a coherent light source that is blurred due to the movement of scatterers within the sample (e.g., red blood cells moving within a tissue sample). Statistical analysis of the spatial distribution can be used to calculate blood flow. In the time domain analysis, a slow counter can be used to obtain time-series fluctuations in light intensity in a sample caused by diffusion of light in the sample that is smoothened due to the movement of scatterers. Statistical analysis of the time-series data can be used to calculate blood flow.
Opening claim text (preview).
What is claimed is: 1. A method for determining blood flow characteristics in deep tissue in a patient, the method comprising: directing coherent light from a laser light source through an input optical fiber comprising an end positioned directly onto a first location on a skin surface of the patient; imaging a second location of the skin surface of the patient via an optical conduit on the skin surface and connected to a detector, wherein a portion of the coherent light is scattered diffusively by the blood flow at a depth of penetration of between 5 mm and 50 mm beneath the patient's skin surface such that the scattered light is at least partially detectable at the second location; sending image data from the second location to a software or hardware processor; calculating the blood flow characteristics based on the image data of the second location, wherein calculating the blood flow characteristics comprises calculating the speckle contrast by statistically analyzing a probability distribution of intensity fluctuations of the scattered light using the software or hardware processor to determine a temporal speckle contrast ratio (K t ) and 1/K t 2 values, and correlating the 1/K t 2 values with blood flow using the software or hardware processor, wherein calculating the blood flow characteristics comprises using statistical analysis without having to rely on autocorrelation analysis on fast time-series data; and signaling the blood flow characteristics calculated from the software or hardware processor to an operator in real time by providing audible, visual, or tactile indicia of the blood flow characteristics. 2. The method of claim 1 , wherein the first and second locations are on a patient's limb. 3. The method of claim 1 , wherein the first and second locations are on a patient's foot. 4. The method of claim 1 , wherein imaging the second location comprises capturing an image with a multi-pixel photodetector. 5. The method of claim 1 , wherein the first and second locations are at least 10 mm apart. 6. A method for determining blood flow characteristics in deep tissue in a patient, the method comprising: directing coherent light from a laser light source through an input optical fiber comprising an end positioned directly onto a first location of the patient's skin surface; imaging a second location of the patient's skin surface via an optical conduit coupled to the skin surface to generate image data, wherein a portion of the coherent light is scattered diffusively by the blood flow at a depth of penetration of between 5 mm and 50 mm beneath the patient's skin surface such that the scattered light is at least partially detectable at the second location; calculating the blood flow characteristics using a spatial domain speckle contrast analysis (sDSCA) system, wherein calculating blood flow characteristics comprises statistically analyzing a probability distribution of speckle intensity fluctuations of the image data using a software or hardware processor to determine spatial speckle contrast ratio (K s ) and 1/K s 2 values, and correlating the 1/K s 2 values with blood flow using the software or hardware processor; and signaling the blood flow characteristics calculated from the software or hardware processor to an operator by providing audible, visual, or tactile indicia of the blood flow characteristics. 7. The method of claim 6 , wherein the first and second locations are on a patient's foot. 8. The method of claim 6 , wherein the first and second locations are at least 10 mm apart. 9. A system for assessment of blood flow characteristics in deep tissue, the system comprising: a coherent laser light source configured to apply light to the tissue; an input optical fiber configured to transmit light from the coherent laser light source, the input optical fiber comprising an end configured to be positioned directly onto a first location of a patient's skin surface; a multi-pixel image sensor configured to be in optical communication with a second location of the patient's skin surface and capture optical information including at least a quantity of light transmitted through the skin surface and into tissue, wherein the light is scattered diffusively, at least in part, by the blood flow at a depth of penetration of between 5 mm and 50 mm; a hardware or software processor configured to analyze the optical information to determine blood flow characteristics in the tissue by determining a spatial speckle contrast ratio (K s ) and 1/K s 2 values, wherein the hardware or software processor is further configured to correlate 1/K s 2 values with blood flow using the hardware or software processor, and wherein the hardware or software processor is configured to use statistical analysis without having to rely on autocorrelation analysis on fast time-series data; and a display configured to provide a signal indicative of the blood flow characteristics determined by the hardware or software processor. 10. The system of claim 9 , wherein the multi-pixel image sensor comprises a CCD detector. 11. The system of claim 9 , wherein the system is configured to provide the signal indicative of the blood flow in real-time. 12. The method of claim 6 , wherein signaling indicative of the blood flow characteristics occurs less than 10 seconds from obtaining the time-series measurements. 13. The method of claim 1 , wherein the input optical fiber comprises a multi-mode fiber and the optical conduit comprises a single-mode fiber. 14. The method of claim 6 , wherein the input optical fiber comprises a multi-mode fiber, and the one or more sensors is operably connected to a single-mode fiber. 15. The system of claim 9 , wherein the input optical fiber comprises a multi-mode fiber and the multi-pixel image sensor is operably connected to a single-mode fiber. 16. The method of claim 1 , wherein the blood flow characteristics comprise blood perfusion.
using correlation, e.g. template matching or determination of similarity · CPC title
using optical means, e.g. infrared light · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.